Complement sensitivity of paroxysmal nocturnal hemoglobinuria bone marrow cells. 1980

J Tumen, and L B Kline, and J W Fay, and D C Scullin, and E G Reisner, and W F Rosse, and A T Huang

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired disorder in which erythrocytes, granulocytes, and platelets are defective, as shown by increased susceptibility of RBCs, WBCs, and platelets to complement-mediated lysis in vitro. The purpose of this study is to determine the sensitivity to complement lysis of PNH and non-PNH erythroid and myeloid precursors using the release of 59Fe and myeloperoxidase as specific markers to monitor the lytic action of complement on erythroid and myeloid cell precursors, respectively. Erythroid cell precursors in four of four PNH patients demonstrated increased sensitivity to complement-mediated lysis. Myeloid cell precursors in four of five PNH patients also exhibited increased sensitivity to complement and antibody. In addition, CFU-c growth was below normal in the marrow of seven PNH patients. These findings support the hypothesis that the defect in PNH occurs at the level of the hematopoietic stem cell.

UI MeSH Term Description Entries
D007048 I Blood-Group System A blood group related both to the ABO and P systems that includes several different antigens found in most people on erythrocytes, in milk, and in saliva. The antibodies react only at low temperatures. Blood-Group System, I,Blood-Group Systems, I,I Blood Group System,I Blood-Group Systems,System, I Blood-Group,Systems, I Blood-Group
D007504 Iron Radioisotopes Unstable isotopes of iron that decay or disintegrate emitting radiation. Fe atoms with atomic weights 52, 53, 55, and 59-61 are radioactive iron isotopes. Radioisotopes, Iron
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009195 Peroxidase A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Myeloperoxidase,Hemi-Myeloperoxidase,Hemi Myeloperoxidase
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003114 Colony-Forming Units Assay A cytologic technique for measuring the functional capacity of stem cells by assaying their activity. Clonogenic Cell Assay,Stem Cell Assay,Clonogenic Cell Assays,Colony Forming Units Assays,Colony-Forming Units Assays,Stem Cell Assays,Assay, Clonogenic Cell,Assay, Colony-Forming Units,Assay, Stem Cell,Assays, Clonogenic Cell,Assays, Colony-Forming Units,Assays, Stem Cell,Colony Forming Units Assay
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System

Related Publications

J Tumen, and L B Kline, and J W Fay, and D C Scullin, and E G Reisner, and W F Rosse, and A T Huang
January 2000, Haematologica,
J Tumen, and L B Kline, and J W Fay, and D C Scullin, and E G Reisner, and W F Rosse, and A T Huang
April 2009, Hematology/oncology clinics of North America,
J Tumen, and L B Kline, and J W Fay, and D C Scullin, and E G Reisner, and W F Rosse, and A T Huang
September 2023, Cureus,
J Tumen, and L B Kline, and J W Fay, and D C Scullin, and E G Reisner, and W F Rosse, and A T Huang
March 1996, Revista clinica espanola,
J Tumen, and L B Kline, and J W Fay, and D C Scullin, and E G Reisner, and W F Rosse, and A T Huang
January 2000, Haematologica,
J Tumen, and L B Kline, and J W Fay, and D C Scullin, and E G Reisner, and W F Rosse, and A T Huang
April 1981, Polski tygodnik lekarski (Warsaw, Poland : 1960),
J Tumen, and L B Kline, and J W Fay, and D C Scullin, and E G Reisner, and W F Rosse, and A T Huang
June 1985, The Journal of clinical investigation,
J Tumen, and L B Kline, and J W Fay, and D C Scullin, and E G Reisner, and W F Rosse, and A T Huang
September 1999, Annals of internal medicine,
J Tumen, and L B Kline, and J W Fay, and D C Scullin, and E G Reisner, and W F Rosse, and A T Huang
December 1986, Zhonghua nei ke za zhi,
J Tumen, and L B Kline, and J W Fay, and D C Scullin, and E G Reisner, and W F Rosse, and A T Huang
July 2018, American journal of clinical pathology,
Copied contents to your clipboard!